BioCytics, Inc. — Form D
BioCytics, Inc. of HUNTERSVILLE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-31. The offering totals $8.0M, of which $1.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-03-31
- Form: D
- Accession: 0001461373-23-000017
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $1.4M
- Remaining: $6.6M
- Minimum investment: $25K
- Investors: 18
- Date of first sale: 2023-02-08
- Revenue range: Decline to Disclose
- SEC file number: 021-477631
Issuer
- Name: BioCytics, Inc.
- CIK: 0001971839
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9801 KINCEY AVE., HUNTERSVILLE, NC, 28078
- Phone: 704-947-6599
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Matthew Pietras | Executive Officer | Huntersville, NC |
| Don L Jackson | Executive Officer | Huntersville, NC |
| Jim Powderly | Executive Officer | Huntersville, NC |
| John Powderly | Director | Huntersville, NC |
| John Powderly | Executive Officer | Huntersville, NC |
| Stacy L Powderly | Executive Officer | Huntersville, NC |
Other filings by this issuer (2)
More